These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 22940451)

  • 1. Alloantigen-stimulated induction and release of CD30 in patients with end-stage renal failure.
    Velásquez SY; Süsal C; Opelz G; García LF; Alvarez CM
    Hum Immunol; 2012 Nov; 73(11):1102-8. PubMed ID: 22940451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of CD30 transcripts with Th1 responses and proinflammatory cytokines in patients with end-stage renal disease.
    Velásquez SY; Opelz G; Rojas M; Süsal C; Alvarez CM
    Hum Immunol; 2016 May; 77(5):403-10. PubMed ID: 26970513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Release of soluble CD30 after allogeneic stimulation is mediated by memory T cells and regulated by IFN-γ and IL-2.
    Velásquez SY; García LF; Opelz G; Alvarez CM; Süsal C
    Transplantation; 2013 Jul; 96(2):154-61. PubMed ID: 23857000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-tumor necrosis factor-alpha response in rheumatoid arthritis is associated with an increase in serum soluble CD30.
    Gerli R; Lunardi C; Bocci EB; Bobbio-Pallavicini F; Schillaci G; Caporali R; Bistoni O; Pirro M; Pitzalis C; Montecucco C
    J Rheumatol; 2008 Jan; 35(1):14-9. PubMed ID: 18061981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased bone marrow (BM) plasma level of soluble CD30 and correlations with BM plasma level of interferon (IFN)-γ, CD4/CD8 T-cell ratio and disease severity in aplastic anemia.
    Wu Q; Zhang J; Shi J; Ge M; Li X; Shao Y; Yao J; Zheng Y
    PLoS One; 2014; 9(11):e110787. PubMed ID: 25383872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of rabbit antithymocyte globulins-induced CD25+ regulatory T cells from cells of patients with end-stage renal disease.
    Sewgobind VD; van der Laan LJ; Kho MM; Kraaijeveld R; Korevaar SS; van Dam T; Ijzermans JN; Weimar W; Baan CC
    Transplantation; 2010 Mar; 89(6):655-66. PubMed ID: 20164820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro soluble CD30 levels in patients with chronic stable coronary artery disease.
    Mahmoudi MJ; Hedayat M; Rezaei N; Saboor-Yaraghi AA; Mahmoudi M
    Iran J Allergy Asthma Immunol; 2011 Dec; 10(4):237-42. PubMed ID: 22184265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TH1/TH2 cytokines and soluble CD30 levels in kidney allograft patients with donor bone marrow cell infusion.
    Solgi G; Amirzagar AA; Pourmand G; Mehrsai AR; Taherimahmoudi M; Baradaran N; Nicknam MH; Ebrahimi Rad MR; Saraji A; Asadpoor AA; Moheiydin M; Nikbin B
    Transplant Proc; 2009 Sep; 41(7):2800-4. PubMed ID: 19765439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-transplant soluble CD30 level as a predictor of not only acute rejection and graft loss but pneumonia in renal transplant recipients.
    Wang D; Wu WZ; Chen JH; Yang SL; Wang QH; Zeng ZX; Tan JM
    Transpl Immunol; 2010 Feb; 22(3-4):115-20. PubMed ID: 20036333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of soluble CD30 in liver transplantation.
    Fábrega E; Unzueta MG; Cobo M; Casafont F; Amado JA; Romero FP
    Transplant Proc; 2007 Sep; 39(7):2295-6. PubMed ID: 17889168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre- and post-transplant monitoring of soluble CD30 levels as predictor of acute renal allograft rejection.
    Wang D; Wu GJ; Wu WZ; Yang SL; Chen JH; Wang H; Lin WH; Wang QH; Zeng ZX; Tan JM
    Transpl Immunol; 2007 Jun; 17(4):278-82. PubMed ID: 17493531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posttransplant soluble CD30 as a predictor of acute renal allograft rejection.
    Kamali K; Abbasi MA; Farokhi B; Abbasi A; Fallah P; Seifee MH; Ghadimi N; Rezaie AR
    Exp Clin Transplant; 2009 Dec; 7(4):237-40. PubMed ID: 20353374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective study of serum soluble CD30 in allogeneic hematopoietic stem cell transplantation.
    Hübel K; Cremer B; Heuser E; von Strandmann EP; Hallek M; Hansen HP
    Transpl Immunol; 2010 Aug; 23(4):215-9. PubMed ID: 20620210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between serum soluble CD30 and serum creatinine before and after renal transplantation.
    López-Hoyos M; San Segundo D; Benito MJ; Fernández-Fresnedo G; Ruiz JC; Rodrigo E; Gómez-Alamillo C; Benito A; Arias M
    Transplant Proc; 2008 Nov; 40(9):2903-5. PubMed ID: 19010142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does pretransplant soluble CD30 serum concentration affect deceased-donor kidney graft function 3 years after transplantation?
    Kovac J; Arnol M; Vidan-Jeras B; Bren AF; Kandus A
    Transplant Proc; 2008 Jun; 40(5):1357-61. PubMed ID: 18589105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma levels of soluble CD30 in kidney graft recipients as predictors of acute allograft rejection.
    Ayed K; Abdallah TB; Bardi R; Abderrahim E; Kheder A
    Transplant Proc; 2006 Sep; 38(7):2300-2. PubMed ID: 16980071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble CD30 serum levels in atopic dermatitis and bronchial asthma and its relationship with disease severity in pediatric age.
    Heshmat NM; El-Hadidi ES
    Pediatr Allergy Immunol; 2006 Jun; 17(4):297-303. PubMed ID: 16771784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Very high levels of soluble CD30 recognize the patients with classical Hodgkin's lymphoma retaining a very poor prognosis.
    Visco C; Nadali G; Vassilakopoulos TP; Bonfante V; Viviani S; Gianni AM; Federico M; Luminari S; Peethambaram P; Witzig TE; Pangalis G; Cabanillas F; Medeiros LJ; Sarris AH; Pizzolo G
    Eur J Haematol; 2006 Nov; 77(5):387-94. PubMed ID: 16879607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological monitoring after organ transplantation: potential role of soluble CD30 blood level measurement.
    Truong DQ; Darwish AA; Gras J; Wieërs G; Cornet A; Robert A; Mourad M; Malaise J; de Ville de Goyet J; Reding R; Latinne D
    Transpl Immunol; 2007 Jun; 17(4):283-7. PubMed ID: 17493532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma soluble CD30 level correlates negatively with age in children.
    Chen JY; Fu LS; Chu JJ; Chen HC; Chi CS
    J Microbiol Immunol Infect; 2007 Apr; 40(2):168-72. PubMed ID: 17446967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.